ICAM1 and hepatocellular carcinoma: Moreover, after insufficient radiofrequency ablation (RFA) for HCC, the upregulation of ICAM-1 in tumor ECs triggers platelet aggregation and activation, leading to increased endothelial permeability through VE-cadherin, and facilitating tumor transendothelial migration.